We are live on
!
Find out more
China SXT Pharmaceuticals
SXTC
SXTC
hedge funds and large institutions have $199K invested in China SXT Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
250% more capital invested
Capital invested by funds: $57K → $199K (+$142K)
5.46% more ownership
Funds ownership: 3.4% → 8.85% (+5.5%)
Holders
Holders Change
–
Holders Change %
–
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$23.5K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$6.15K |
| 3 |
LFAS
Level Four Advisory Services
Dallas,
Texas
|
-$5.26K |
| 4 |
HF
HRT Financial
New York
|
-$5K |
| 5 |
BBA
Baader Bank Aktiengesellschaft
Unterschleissheim,
Germany
|
-$1.42K |